Annexin Pharmaceuticals AB (OSTO:ANNX) Cyclically Adjusted Book per Share: kr53.80 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ANNX Annexin Pharmaceuticals AB OSTO:ANNX
16 GF Score
Price kr12.80
! 1 Warning Sign
View Full Analysis

What is Annexin Pharmaceuticals AB Cyclically Adjusted Book per Share?

Annexin Pharmaceuticals AB OSTO:ANNX -1.54% 16 Cyclically Adjusted Book per Share is kr53.80 as of Jun. 2026. GuruFocus rates OSTO:ANNX with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Annexin Pharmaceuticals AB's adjusted book value per share for the three months ended in Jun. 2026 was kr0.357. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr53.80 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-09-14), Annexin Pharmaceuticals AB's current stock price is kr12.80. Annexin Pharmaceuticals AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was kr53.80. Annexin Pharmaceuticals AB's Cyclically Adjusted PB Ratio of today is 0.24.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Annexin Pharmaceuticals AB was 0.24. The lowest was 0.00. And the median was 0.00.


Annexin Pharmaceuticals AB  (OSTO:ANNX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Annexin Pharmaceuticals AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=12.80/53.80
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Annexin Pharmaceuticals AB was 0.24. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Annexin Pharmaceuticals AB Cyclically Adjusted Book per Share Related Terms


Annexin Pharmaceuticals AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Annexin Pharmaceuticals AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Annexin Pharmaceuticals AB Cyclically Adjusted Book per Share Chart

Annexin Pharmaceuticals AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 56.13

Annexin Pharmaceuticals AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 56.04 56.13 54.77 53.80

OSTO:ANNX vs VRTX, REGN, MRNA: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Annexin Pharmaceuticals AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Annexin Pharmaceuticals AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annexin Pharmaceuticals AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Annexin Pharmaceuticals AB's Cyclically Adjusted PB Ratio falls into.


OSTO:ANNX
16GF Score
Annexin Pharmaceuticals AB OSTO:ANNX
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Annexin Pharmaceuticals AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Annexin Pharmaceuticals AB's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.357/134.6100*134.6100
=0.357

Current CPI (Jun. 2026) = 134.6100.

Annexin Pharmaceuticals AB Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.000 101.138 0.000
201612 97.338 102.022 128.430
201703 261.576 102.022 345.131
201706 205.832 102.752 269.649
201709 184.728 103.279 240.768
201712 132.821 103.793 172.257
201803 83.984 103.962 108.743
201806 94.290 104.875 121.024
201809 85.521 105.679 108.934
201812 72.323 105.912 91.920
201903 62.260 105.886 79.149
201906 51.388 106.742 64.805
201909 39.648 107.214 49.779
201912 20.849 107.766 26.042
202003 39.590 106.563 50.010
202006 30.966 107.498 38.776
202009 25.351 107.635 31.704
202012 14.136 108.296 17.571
202103 1.082 108.360 1.344
202106 10.212 108.928 12.620
202109 5.158 110.338 6.293
202112 18.565 112.486 22.216
202203 14.811 114.825 17.363
202206 12.215 118.384 13.889
202209 11.670 122.296 12.845
202212 10.640 126.365 11.334
202303 6.750 127.042 7.152
202306 3.864 129.407 4.019
202309 0.214 130.224 0.221
202312 4.885 131.912 4.985
202403 1.648 132.205 1.678
202406 6.504 132.716 6.597
202409 4.527 132.304 4.606
202412 2.475 132.987 2.505
202503 6.382 132.825 6.468
202506 6.328 133.699 6.371
202509 4.947 133.480 4.989
202512 3.479 133.390 3.511
202603 2.012 133.560 2.028
202606 0.357 134.610 0.357

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr53.80 mean?
Annexin Pharmaceuticals AB (OSTO:ANNX) has a Cyclically Adjusted Book per Share of kr53.80 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Annexin Pharmaceuticals AB and its competitors.
Is Annexin Pharmaceuticals AB's Cyclically Adjusted Book per Share too high?
Annexin Pharmaceuticals AB's current Cyclically Adjusted Book per Share is kr53.80. Overall, Annexin Pharmaceuticals AB has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Annexin Pharmaceuticals AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Annexin Pharmaceuticals AB's Cyclically Adjusted Book per Share of kr53.80 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Annexin Pharmaceuticals AB and its competitors. Annexin Pharmaceuticals AB's current Cyclically Adjusted Book per Share is kr53.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annexin Pharmaceuticals AB stock overvalued right now?
Annexin Pharmaceuticals AB (OSTO:ANNX) has a current Cyclically Adjusted Book per Share of kr53.80. The current Cyclically Adjusted Book per Share is kr53.80. Annexin Pharmaceuticals AB's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Annexin Pharmaceuticals AB (OSTO:ANNX), the current Cyclically Adjusted Book per Share is kr53.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Annexin Pharmaceuticals AB Business Description

Other Exchanges Q910:Germany
Address Kammakargatan 48, Stockholm, SWE, 111 60
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.
16GF Score

Get the complete analysis for OSTO:ANNX

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr12.80
Price